Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.94B | $ 3.33B | $ 2.75B | $ 2.49B | $ 1.48B |
Total Assets | $ 100.57B | $ 94.86B | $ 88.94B | $ 67.22B | $ 65.78B |
Total Debt | $ 48.59B | $ 45.47B | $ 43.90B | $ 31.22B | $ 32.02B |
Net Debt | $ 45.65B | $ 42.13B | $ 41.14B | $ 28.73B | $ 30.54B |
Total Liabilities | $ 74.62B | $ 71.00B | $ 68.30B | $ 47.36B | $ 47.43B |
Stockholders Equity | $ 25.93B | $ 23.83B | $ 20.62B | $ 19.84B | $ 18.32B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |